In the above-mentioned work, anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis by J.M. Oldhoff, U. Darsow, and others, the team tested the effectiveness of asthma therapy on AD patients. The gene discussed is IL5; the disease is atopic eczema.